Prospective Study of Single vs. Two Unit Umbilical Cord Blood Transplantation Following Reduced Intensity Conditioning in Adults with Hematologic Malignancies

As the threshold nucleated cell dose for single unit umbilical cord blood (UCB) in adults has not to date been firmly established, we prospectively compared single vs. 2-unit UCB transplantation after reduced intensity conditioning (RIC) in adult patients with hematologic malignancies. Study design...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Bone marrow transplantation (Basingstoke) 2011-10, Vol.47 (7), p.924-933
Hauptverfasser: Kindwall-Keller, Tamila L., Hegerfeldt, Yael, Meyerson, Howard J., Margevicius, Seunghee, Fu, Pingfu, van Heeckeren, Willem, Lazarus, Hillard M., Cooper, Brenda W., Gerson, Stanton L., Barr, Paul, Tse, William W., Curtis, Christine, Fanning, Laura R., Creger, Richard J., Carlson-Barko, Joanne M., Laughlin, Mary J.
Format: Artikel
Sprache:eng
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 933
container_issue 7
container_start_page 924
container_title Bone marrow transplantation (Basingstoke)
container_volume 47
creator Kindwall-Keller, Tamila L.
Hegerfeldt, Yael
Meyerson, Howard J.
Margevicius, Seunghee
Fu, Pingfu
van Heeckeren, Willem
Lazarus, Hillard M.
Cooper, Brenda W.
Gerson, Stanton L.
Barr, Paul
Tse, William W.
Curtis, Christine
Fanning, Laura R.
Creger, Richard J.
Carlson-Barko, Joanne M.
Laughlin, Mary J.
description As the threshold nucleated cell dose for single unit umbilical cord blood (UCB) in adults has not to date been firmly established, we prospectively compared single vs. 2-unit UCB transplantation after reduced intensity conditioning (RIC) in adult patients with hematologic malignancies. Study design specified one UCB unit if the cryopreserved total nucleated cell (TNC) dose was ≥2.5×10 7 /kg recipient weight, otherwise 2-units matched at minimum 4/6 HLA loci to the patient and 3/6 to each other were infused. Twenty-seven patients received 1 unit; 23 patients received 2 units. Median time to absolute neutrophil count (ANC) >500/μL was 24 days (95% CI 22–28 days), 25 days for 1-unit and 23 days for 2-units (p=0.99). At day 100, ANC >500/μL was 88.4% and 91.3% in the 1 and 2-unit groups (p=0.99), respectively. Three-year event free survival (EFS) was 28.6% and 39.1% in the 1 and 2-unit groups (p=0.71), respectively. Infusion of 2 units was associated with significantly lower relapse risk, 30.4% vs. 59.3% (p=0.045). Infused cell doses (TNC, CD3 + , CD34 + , CD56 + CD3 neg ) did not impact engraftment, overall survival (OS), or EFS. Taken together, single unit UCB transplantation with threshold cell dose ≥2.5×10 7 /kg recipient weight after RIC is a viable option for adults, although infusion of 2 units confers a lower relapse incidence.
doi_str_mv 10.1038/bmt.2011.195
format Article
fullrecord <record><control><sourceid>pubmedcentral</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_3262108</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>pubmedcentral_primary_oai_pubmedcentral_nih_gov_3262108</sourcerecordid><originalsourceid>FETCH-pubmedcentral_primary_oai_pubmedcentral_nih_gov_32621083</originalsourceid><addsrcrecordid>eNqljMtOwzAQRS0EouWx4wPmBxps50G6QYKKqiyQEG3XkRu76SBnJoqdVv0ZvhUqsWHN6i7OPUeIOyUTJdPyftPGREulEjXNz8RYZQ_FJE-L_FyMpS7KSZoW05G4CuFTSpVlMr8UI62l1FlZjsXXe8-hc3XEvYNlHOwReAtLpMY72IcEVgeGNWGEdbtBj7XxMOPewrNntrDqDYXOG4omIhPM2Xs-_Njw4exQOwuvFB0FjMcfjSyeXieMBE928DHAAeMOFq41kT03WMOb8diQoRpduBEXW-ODu_3da_E4f1nNFpNu2LTO1o5ib3zV9dia_lixweovIdxVDe-rVBdayTL9d-AbsLV7BQ</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype></control><display><type>article</type><title>Prospective Study of Single vs. Two Unit Umbilical Cord Blood Transplantation Following Reduced Intensity Conditioning in Adults with Hematologic Malignancies</title><source>SpringerLink Journals</source><source>Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals</source><source>Nature Journals Online</source><creator>Kindwall-Keller, Tamila L. ; Hegerfeldt, Yael ; Meyerson, Howard J. ; Margevicius, Seunghee ; Fu, Pingfu ; van Heeckeren, Willem ; Lazarus, Hillard M. ; Cooper, Brenda W. ; Gerson, Stanton L. ; Barr, Paul ; Tse, William W. ; Curtis, Christine ; Fanning, Laura R. ; Creger, Richard J. ; Carlson-Barko, Joanne M. ; Laughlin, Mary J.</creator><creatorcontrib>Kindwall-Keller, Tamila L. ; Hegerfeldt, Yael ; Meyerson, Howard J. ; Margevicius, Seunghee ; Fu, Pingfu ; van Heeckeren, Willem ; Lazarus, Hillard M. ; Cooper, Brenda W. ; Gerson, Stanton L. ; Barr, Paul ; Tse, William W. ; Curtis, Christine ; Fanning, Laura R. ; Creger, Richard J. ; Carlson-Barko, Joanne M. ; Laughlin, Mary J.</creatorcontrib><description>As the threshold nucleated cell dose for single unit umbilical cord blood (UCB) in adults has not to date been firmly established, we prospectively compared single vs. 2-unit UCB transplantation after reduced intensity conditioning (RIC) in adult patients with hematologic malignancies. Study design specified one UCB unit if the cryopreserved total nucleated cell (TNC) dose was ≥2.5×10 7 /kg recipient weight, otherwise 2-units matched at minimum 4/6 HLA loci to the patient and 3/6 to each other were infused. Twenty-seven patients received 1 unit; 23 patients received 2 units. Median time to absolute neutrophil count (ANC) &gt;500/μL was 24 days (95% CI 22–28 days), 25 days for 1-unit and 23 days for 2-units (p=0.99). At day 100, ANC &gt;500/μL was 88.4% and 91.3% in the 1 and 2-unit groups (p=0.99), respectively. Three-year event free survival (EFS) was 28.6% and 39.1% in the 1 and 2-unit groups (p=0.71), respectively. Infusion of 2 units was associated with significantly lower relapse risk, 30.4% vs. 59.3% (p=0.045). Infused cell doses (TNC, CD3 + , CD34 + , CD56 + CD3 neg ) did not impact engraftment, overall survival (OS), or EFS. Taken together, single unit UCB transplantation with threshold cell dose ≥2.5×10 7 /kg recipient weight after RIC is a viable option for adults, although infusion of 2 units confers a lower relapse incidence.</description><identifier>ISSN: 0268-3369</identifier><identifier>EISSN: 1476-5365</identifier><identifier>DOI: 10.1038/bmt.2011.195</identifier><identifier>PMID: 22002488</identifier><language>eng</language><ispartof>Bone marrow transplantation (Basingstoke), 2011-10, Vol.47 (7), p.924-933</ispartof><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>230,314,777,781,882,27905,27906</link.rule.ids></links><search><creatorcontrib>Kindwall-Keller, Tamila L.</creatorcontrib><creatorcontrib>Hegerfeldt, Yael</creatorcontrib><creatorcontrib>Meyerson, Howard J.</creatorcontrib><creatorcontrib>Margevicius, Seunghee</creatorcontrib><creatorcontrib>Fu, Pingfu</creatorcontrib><creatorcontrib>van Heeckeren, Willem</creatorcontrib><creatorcontrib>Lazarus, Hillard M.</creatorcontrib><creatorcontrib>Cooper, Brenda W.</creatorcontrib><creatorcontrib>Gerson, Stanton L.</creatorcontrib><creatorcontrib>Barr, Paul</creatorcontrib><creatorcontrib>Tse, William W.</creatorcontrib><creatorcontrib>Curtis, Christine</creatorcontrib><creatorcontrib>Fanning, Laura R.</creatorcontrib><creatorcontrib>Creger, Richard J.</creatorcontrib><creatorcontrib>Carlson-Barko, Joanne M.</creatorcontrib><creatorcontrib>Laughlin, Mary J.</creatorcontrib><title>Prospective Study of Single vs. Two Unit Umbilical Cord Blood Transplantation Following Reduced Intensity Conditioning in Adults with Hematologic Malignancies</title><title>Bone marrow transplantation (Basingstoke)</title><description>As the threshold nucleated cell dose for single unit umbilical cord blood (UCB) in adults has not to date been firmly established, we prospectively compared single vs. 2-unit UCB transplantation after reduced intensity conditioning (RIC) in adult patients with hematologic malignancies. Study design specified one UCB unit if the cryopreserved total nucleated cell (TNC) dose was ≥2.5×10 7 /kg recipient weight, otherwise 2-units matched at minimum 4/6 HLA loci to the patient and 3/6 to each other were infused. Twenty-seven patients received 1 unit; 23 patients received 2 units. Median time to absolute neutrophil count (ANC) &gt;500/μL was 24 days (95% CI 22–28 days), 25 days for 1-unit and 23 days for 2-units (p=0.99). At day 100, ANC &gt;500/μL was 88.4% and 91.3% in the 1 and 2-unit groups (p=0.99), respectively. Three-year event free survival (EFS) was 28.6% and 39.1% in the 1 and 2-unit groups (p=0.71), respectively. Infusion of 2 units was associated with significantly lower relapse risk, 30.4% vs. 59.3% (p=0.045). Infused cell doses (TNC, CD3 + , CD34 + , CD56 + CD3 neg ) did not impact engraftment, overall survival (OS), or EFS. Taken together, single unit UCB transplantation with threshold cell dose ≥2.5×10 7 /kg recipient weight after RIC is a viable option for adults, although infusion of 2 units confers a lower relapse incidence.</description><issn>0268-3369</issn><issn>1476-5365</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2011</creationdate><recordtype>article</recordtype><recordid>eNqljMtOwzAQRS0EouWx4wPmBxps50G6QYKKqiyQEG3XkRu76SBnJoqdVv0ZvhUqsWHN6i7OPUeIOyUTJdPyftPGREulEjXNz8RYZQ_FJE-L_FyMpS7KSZoW05G4CuFTSpVlMr8UI62l1FlZjsXXe8-hc3XEvYNlHOwReAtLpMY72IcEVgeGNWGEdbtBj7XxMOPewrNntrDqDYXOG4omIhPM2Xs-_Njw4exQOwuvFB0FjMcfjSyeXieMBE928DHAAeMOFq41kT03WMOb8diQoRpduBEXW-ODu_3da_E4f1nNFpNu2LTO1o5ib3zV9dia_lixweovIdxVDe-rVBdayTL9d-AbsLV7BQ</recordid><startdate>20111017</startdate><enddate>20111017</enddate><creator>Kindwall-Keller, Tamila L.</creator><creator>Hegerfeldt, Yael</creator><creator>Meyerson, Howard J.</creator><creator>Margevicius, Seunghee</creator><creator>Fu, Pingfu</creator><creator>van Heeckeren, Willem</creator><creator>Lazarus, Hillard M.</creator><creator>Cooper, Brenda W.</creator><creator>Gerson, Stanton L.</creator><creator>Barr, Paul</creator><creator>Tse, William W.</creator><creator>Curtis, Christine</creator><creator>Fanning, Laura R.</creator><creator>Creger, Richard J.</creator><creator>Carlson-Barko, Joanne M.</creator><creator>Laughlin, Mary J.</creator><scope>5PM</scope></search><sort><creationdate>20111017</creationdate><title>Prospective Study of Single vs. Two Unit Umbilical Cord Blood Transplantation Following Reduced Intensity Conditioning in Adults with Hematologic Malignancies</title><author>Kindwall-Keller, Tamila L. ; Hegerfeldt, Yael ; Meyerson, Howard J. ; Margevicius, Seunghee ; Fu, Pingfu ; van Heeckeren, Willem ; Lazarus, Hillard M. ; Cooper, Brenda W. ; Gerson, Stanton L. ; Barr, Paul ; Tse, William W. ; Curtis, Christine ; Fanning, Laura R. ; Creger, Richard J. ; Carlson-Barko, Joanne M. ; Laughlin, Mary J.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-pubmedcentral_primary_oai_pubmedcentral_nih_gov_32621083</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2011</creationdate><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Kindwall-Keller, Tamila L.</creatorcontrib><creatorcontrib>Hegerfeldt, Yael</creatorcontrib><creatorcontrib>Meyerson, Howard J.</creatorcontrib><creatorcontrib>Margevicius, Seunghee</creatorcontrib><creatorcontrib>Fu, Pingfu</creatorcontrib><creatorcontrib>van Heeckeren, Willem</creatorcontrib><creatorcontrib>Lazarus, Hillard M.</creatorcontrib><creatorcontrib>Cooper, Brenda W.</creatorcontrib><creatorcontrib>Gerson, Stanton L.</creatorcontrib><creatorcontrib>Barr, Paul</creatorcontrib><creatorcontrib>Tse, William W.</creatorcontrib><creatorcontrib>Curtis, Christine</creatorcontrib><creatorcontrib>Fanning, Laura R.</creatorcontrib><creatorcontrib>Creger, Richard J.</creatorcontrib><creatorcontrib>Carlson-Barko, Joanne M.</creatorcontrib><creatorcontrib>Laughlin, Mary J.</creatorcontrib><collection>PubMed Central (Full Participant titles)</collection><jtitle>Bone marrow transplantation (Basingstoke)</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Kindwall-Keller, Tamila L.</au><au>Hegerfeldt, Yael</au><au>Meyerson, Howard J.</au><au>Margevicius, Seunghee</au><au>Fu, Pingfu</au><au>van Heeckeren, Willem</au><au>Lazarus, Hillard M.</au><au>Cooper, Brenda W.</au><au>Gerson, Stanton L.</au><au>Barr, Paul</au><au>Tse, William W.</au><au>Curtis, Christine</au><au>Fanning, Laura R.</au><au>Creger, Richard J.</au><au>Carlson-Barko, Joanne M.</au><au>Laughlin, Mary J.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Prospective Study of Single vs. Two Unit Umbilical Cord Blood Transplantation Following Reduced Intensity Conditioning in Adults with Hematologic Malignancies</atitle><jtitle>Bone marrow transplantation (Basingstoke)</jtitle><date>2011-10-17</date><risdate>2011</risdate><volume>47</volume><issue>7</issue><spage>924</spage><epage>933</epage><pages>924-933</pages><issn>0268-3369</issn><eissn>1476-5365</eissn><abstract>As the threshold nucleated cell dose for single unit umbilical cord blood (UCB) in adults has not to date been firmly established, we prospectively compared single vs. 2-unit UCB transplantation after reduced intensity conditioning (RIC) in adult patients with hematologic malignancies. Study design specified one UCB unit if the cryopreserved total nucleated cell (TNC) dose was ≥2.5×10 7 /kg recipient weight, otherwise 2-units matched at minimum 4/6 HLA loci to the patient and 3/6 to each other were infused. Twenty-seven patients received 1 unit; 23 patients received 2 units. Median time to absolute neutrophil count (ANC) &gt;500/μL was 24 days (95% CI 22–28 days), 25 days for 1-unit and 23 days for 2-units (p=0.99). At day 100, ANC &gt;500/μL was 88.4% and 91.3% in the 1 and 2-unit groups (p=0.99), respectively. Three-year event free survival (EFS) was 28.6% and 39.1% in the 1 and 2-unit groups (p=0.71), respectively. Infusion of 2 units was associated with significantly lower relapse risk, 30.4% vs. 59.3% (p=0.045). Infused cell doses (TNC, CD3 + , CD34 + , CD56 + CD3 neg ) did not impact engraftment, overall survival (OS), or EFS. Taken together, single unit UCB transplantation with threshold cell dose ≥2.5×10 7 /kg recipient weight after RIC is a viable option for adults, although infusion of 2 units confers a lower relapse incidence.</abstract><pmid>22002488</pmid><doi>10.1038/bmt.2011.195</doi><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0268-3369
ispartof Bone marrow transplantation (Basingstoke), 2011-10, Vol.47 (7), p.924-933
issn 0268-3369
1476-5365
language eng
recordid cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_3262108
source SpringerLink Journals; Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals; Nature Journals Online
title Prospective Study of Single vs. Two Unit Umbilical Cord Blood Transplantation Following Reduced Intensity Conditioning in Adults with Hematologic Malignancies
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-18T04%3A17%3A32IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-pubmedcentral&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Prospective%20Study%20of%20Single%20vs.%20Two%20Unit%20Umbilical%20Cord%20Blood%20Transplantation%20Following%20Reduced%20Intensity%20Conditioning%20in%20Adults%20with%20Hematologic%20Malignancies&rft.jtitle=Bone%20marrow%20transplantation%20(Basingstoke)&rft.au=Kindwall-Keller,%20Tamila%20L.&rft.date=2011-10-17&rft.volume=47&rft.issue=7&rft.spage=924&rft.epage=933&rft.pages=924-933&rft.issn=0268-3369&rft.eissn=1476-5365&rft_id=info:doi/10.1038/bmt.2011.195&rft_dat=%3Cpubmedcentral%3Epubmedcentral_primary_oai_pubmedcentral_nih_gov_3262108%3C/pubmedcentral%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/22002488&rfr_iscdi=true